These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3180085)
1. Late target protein of the carcinogen N-2-fluorenylacetamide in rat liver. Munir KM; Blackburn GR; Sorof S Cancer Res; 1988 Dec; 48(23):6745-52. PubMed ID: 3180085 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Sorof S; Custer RP Cancer Res; 1987 Jan; 47(1):210-20. PubMed ID: 3791207 [TBL] [Abstract][Full Text] [Related]
3. Normal hepatocytes exhibiting histone H3 with antibody accessible sites that are cryptic in carcinogen-altered hepatocytes. Munir KM; Custer RP; Sorof S Cancer Res; 1989 Jan; 49(2):424-32. PubMed ID: 2910459 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing the binding of N-2-fluorenylacetamide to specific regions of the hepatic genome in vivo in rats. Schwartz EL; Braselton WE; Goodman JI J Natl Cancer Inst; 1981 Apr; 66(4):667-72. PubMed ID: 6939914 [TBL] [Abstract][Full Text] [Related]
5. Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Bassuk JA; Tsichlis PN; Sorof S Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7547-51. PubMed ID: 3478711 [TBL] [Abstract][Full Text] [Related]
6. A new nucleosomal protein in normal liver related to the cytoplasmic polypeptide target of a carcinogen. Bassuk JA; Sorof S Mol Cell Biochem; 1985 Sep; 68(1):49-57. PubMed ID: 4058425 [TBL] [Abstract][Full Text] [Related]
7. An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen. Blackburn GR; Andrews JP; Rao KV; Sorof S Cancer Res; 1980 Dec; 40(12):4688-93. PubMed ID: 7438100 [TBL] [Abstract][Full Text] [Related]
8. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Maeura Y; Weisburger JH; Williams GM Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970 [TBL] [Abstract][Full Text] [Related]
9. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites. Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585 [TBL] [Abstract][Full Text] [Related]
10. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Custer RP; Sorof S Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6738-42. PubMed ID: 6593726 [TBL] [Abstract][Full Text] [Related]
11. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
12. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development. Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222 [TBL] [Abstract][Full Text] [Related]
13. Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen. Custer RP; Sorof S Differentiation; 1985; 30(2):176-81. PubMed ID: 3830751 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-2-fluorenylacetamide-induced mammary tumorigenesis in rats by dietary polybrominated biphenyls. Schwartz EL; Kluwe WM; Sleight SD; Hook JB; Goodman JI J Natl Cancer Inst; 1980 Jan; 64(1):63-7. PubMed ID: 6243377 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
16. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Ringer DP; Norton TR; Howell BA Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938 [TBL] [Abstract][Full Text] [Related]
17. Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen. Vinores SA; Churey JJ; Haller JM; Schnabel SJ; Custer RP; Sorof S Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2092-6. PubMed ID: 6585789 [TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of 26- and 30-kDa rat liver proteins immunoreactive to anti-sterol carrier protein-2 antibodies. Pu L; Foxworth WB; Kier AB; Annan RS; Carr SA; Edmondson R; Russell D; Wood WG; Schroeder F Protein Expr Purif; 1998 Aug; 13(3):337-48. PubMed ID: 9693058 [TBL] [Abstract][Full Text] [Related]
20. Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. Wolkoff AW; Chung CT J Clin Invest; 1980 May; 65(5):1152-61. PubMed ID: 7364942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]